{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:20:55Z","timestamp":1793830855183,"version":"4.6.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFF1100604"],"award-info":[{"award-number":["2022YFF1100604"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.aohep.2023.101177","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T09:24:11Z","timestamp":1699003451000},"page":"101177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Non-linear associations of circulating total bilirubin concentration with the risk of nonalcoholic fatty liver disease and all-cause mortality"],"prefix":"10.1016","volume":"29","author":[{"given":"Hui","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingtao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuojing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6978-2061","authenticated-orcid":false,"given":"Zhaoping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10290","key":"10.1016\/j.aohep.2023.101177_bib0001","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.aohep.2023.101177_bib0002","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/hep.31173","article-title":"Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD","volume":"72","author":"Paik","year":"2020","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.aohep.2023.101177_bib0003","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2023.101177_bib0004","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10654-019-00589-0","article-title":"Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study","volume":"35","author":"Kunutsor","year":"2020","journal-title":"Eur J Epidemiol"},{"issue":"11","key":"10.1016\/j.aohep.2023.101177_bib0005","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/oby.23263","article-title":"Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease","volume":"29","author":"Barb","year":"2021","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"10.1016\/j.aohep.2023.101177_bib0006","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States national health and nutrition examination survey","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.aohep.2023.101177_bib0007","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.aohep.2023.101177_bib0008","doi-asserted-by":"crossref","first-page":"16093","DOI":"10.1073\/pnas.252626999","article-title":"Biliverdin reductase: a major physiologic cytoprotectant","volume":"99","author":"Baranano","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4792","key":"10.1016\/j.aohep.2023.101177_bib0009","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.3029864","article-title":"Bilirubin is an antioxidant of possible physiological importance","volume":"235","author":"Stocker","year":"1987","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.aohep.2023.101177_bib0010","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3390\/antiox10091352","article-title":"Serum bilirubin levels in overweight and obese individuals: the importance of anti-inflammatory and antioxidant responses","volume":"10","author":"Ziberna","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"12","key":"10.1016\/j.aohep.2023.101177_bib0011","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.biocel.2013.09.014","article-title":"The molecular basis for the immunomodulatory activities of unconjugated bilirubin","volume":"45","author":"Jangi","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"10.1016\/j.aohep.2023.101177_bib0012","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.molmed.2023.01.007","article-title":"The physiology of bilirubin: health and disease equilibrium","volume":"29","author":"Vitek","year":"2023","journal-title":"Trends Mol Med"},{"issue":"4","key":"10.1016\/j.aohep.2023.101177_bib0013","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3350\/cmh.2012.18.4.383","article-title":"Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease","volume":"18","author":"Kwak","year":"2012","journal-title":"Clin Mol Hepatol"},{"issue":"9","key":"10.1016\/j.aohep.2023.101177_bib0014","doi-asserted-by":"crossref","first-page":"522","DOI":"10.21037\/atm-22-1187","article-title":"Association between bilirubin and nonalcoholic fatty liver disease in the non-obese Chinese population: a cross-sectional study","volume":"10","author":"Shu","year":"2022","journal-title":"Ann Transl Med"},{"issue":"13","key":"10.1016\/j.aohep.2023.101177_bib0015","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.3390\/jcm10132812","article-title":"Association of serum bilirubin level with metabolic syndrome and non-alcoholic fatty liver disease: a cross-sectional study of 1672 obese children","volume":"10","author":"Bellarosa","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.aohep.2023.101177_bib0016","doi-asserted-by":"crossref","first-page":"31006","DOI":"10.1038\/srep31006","article-title":"Association between bilirubin and risk of Non-Alcoholic Fatty Liver Disease based on a prospective cohort study","volume":"6","author":"Tian","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.aohep.2023.101177_bib0017","doi-asserted-by":"crossref","first-page":"e37241","DOI":"10.1371\/journal.pone.0037241","article-title":"A cohort study of serum bilirubin levels and incident non-alcoholic fatty liver disease in middle aged Korean workers","volume":"7","author":"Chang","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.aohep.2023.101177_bib0018","doi-asserted-by":"crossref","first-page":"13224","DOI":"10.1038\/s41598-021-92442-2","article-title":"Association of serum bilirubin levels with risk of cancer development and total death","volume":"11","author":"Inoguchi","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.aohep.2023.101177_bib0019","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/4688900","article-title":"Association of serum total bilirubin concentration with telomere length: the national health and nutrition examination survey","volume":"2021","author":"Hao","year":"2021","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"10.1016\/j.aohep.2023.101177_bib0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/07853890.2017.1377846","article-title":"Direct, indirect and total bilirubin and risk of incident coronary heart disease in the Dongfeng-Tongji cohort","volume":"50","author":"Lai","year":"2018","journal-title":"Ann Med"},{"key":"10.1016\/j.aohep.2023.101177_bib0021","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4603087","article-title":"The U-shaped association between bilirubin and diabetic retinopathy risk: a five-year cohort based on 5323 male diabetic patients","author":"Liu","year":"2018","journal-title":"J Diabetes Res"},{"issue":"9","key":"10.1016\/j.aohep.2023.101177_bib0022","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.molmed.2016.07.004","article-title":"A novel perspective on the biology of bilirubin in health and disease","volume":"22","author":"Gazzin","year":"2016","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.aohep.2023.101177_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20140566","article-title":"Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases","volume":"129","author":"Wagner","year":"2015","journal-title":"Clinical Sci (London, England : 1979)"},{"issue":"Suppl 1","key":"10.1016\/j.aohep.2023.101177_bib0024","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.33549\/physiolres.933581","article-title":"Bilirubin and atherosclerotic diseases","volume":"66","author":"V\u00edtek","year":"2017","journal-title":"Physiol Res"},{"issue":"6","key":"10.1016\/j.aohep.2023.101177_bib0025","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","article-title":"European Association for the Study of D, European Association for the Study of O. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"59","year":"2016","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.aohep.2023.101177_bib0026","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1093\/jn\/nxab253","article-title":"Intake of nuts and seeds is associated with a lower prevalence of nonalcoholic fatty liver disease in us adults: findings from 2005-2018 NHANES","volume":"151","author":"Cardoso","year":"2021","journal-title":"J Nutr"},{"issue":"12","key":"10.1016\/j.aohep.2023.101177_bib0027","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1016\/j.cgh.2021.12.015","article-title":"Prevalence of high and moderate risk nonalcoholic fatty liver disease among adults in the United States, 1999-2016","volume":"20","author":"Golabi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2023.101177_bib0028","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/ATVBAHA.122.318086","article-title":"Association between serum bilirubin, lipid levels, and prevalence of femoral and carotid atherosclerosis: a population-based cross-sectional study","volume":"43","author":"Su","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.aohep.2023.101177_bib0029","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015799","article-title":"Baseline serum bilirubin and risk of first stroke in hypertensive patients","volume":"9","author":"Wang","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"13","key":"10.1016\/j.aohep.2023.101177_bib0030","doi-asserted-by":"crossref","first-page":"10614","DOI":"10.3390\/ijms241310614","article-title":"Association of low serum bilirubin concentrations and promoter variations in the UGT1A1 and HMOX1 genes with type 2 diabetes mellitus in the czech population","volume":"24","author":"Jir\u00e1skov\u00e1","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.aohep.2023.101177_bib0031","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fphar.2012.00055","article-title":"The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases","volume":"3","author":"V\u00edtek","year":"2012","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.aohep.2023.101177_bib0032","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3389\/fgene.2018.00662","article-title":"Genetically regulated bilirubin and risk of non-alcoholic fatty liver disease: a mendelian randomization study","volume":"9","author":"Luo","year":"2018","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.aohep.2023.101177_bib0033","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/MPG.0b013e318291fefe","article-title":"Serum bilirubin level is inversely associated with nonalcoholic steatohepatitis in children","volume":"57","author":"Puri","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"10.1016\/j.aohep.2023.101177_bib0034","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.aohep.2023.101177_bib0035","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/j.1365-2036.2006.02939.x","article-title":"Serum bilirubin and colorectal cancer risk: a population-based cohort study","volume":"23","author":"Ioannou","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.aohep.2023.101177_bib0036","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/med.21660","article-title":"Bilirubin as a signaling molecule","volume":"40","author":"V\u00edtek","year":"2020","journal-title":"Med Res Rev"},{"issue":"6","key":"10.1016\/j.aohep.2023.101177_bib0037","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jhep.2021.06.010","article-title":"Bilirubin: The yellow hormone?","volume":"75","author":"V\u00edtek","year":"2021","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.aohep.2023.101177_bib0038","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/liv.13351","article-title":"The molecular basis of jaundice: an old symptom revisited","volume":"37","author":"Gazzin","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2023.101177_bib0039","doi-asserted-by":"crossref","first-page":"22300","DOI":"10.1038\/srep22300","article-title":"Longer telomeres in chronic, moderate, unconjugated hyperbilirubinaemia: insights from a human study on Gilbert's syndrome","volume":"6","author":"Tosevska","year":"2016","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.aohep.2023.101177_bib0040","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/clinchem\/41.10.1504","article-title":"Serum bilirubin and risk of ischemic heart disease in middle-aged British men","volume":"41","author":"Breimer","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.aohep.2023.101177_bib0041","article-title":"Association of total bilirubin with all-cause and cardiovascular mortality in the general population","volume":"8","author":"Chen","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.aohep.2023.101177_bib0042","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/HYPERTENSIONAHA.114.04915","article-title":"Longitudinal blood pressure control, long-term mortality, and predictive utility of serum liver enzymes and bilirubin in hypertensive patients","volume":"66","author":"McCallum","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.aohep.2023.101177_bib0043","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2017.09.001","article-title":"Relationship between serum total bilirubin levels and mortality in uremia patients undergoing long-term hemodialysis: a nationwide cohort study","volume":"265","author":"Su","year":"2017","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.aohep.2023.101177_bib0044","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3390\/jcm9061727","article-title":"Bilirubin-A possible prognostic mortality marker for patients with ECLS","volume":"9","author":"Bunte","year":"2020","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.aohep.2023.101177_bib0045","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.aohep.2019.02.001","article-title":"Association between plasma bilirubin and mortality","volume":"18","author":"Vitek","year":"2019","journal-title":"Ann Hepatol"},{"issue":"12","key":"10.1016\/j.aohep.2023.101177_bib0046","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007507","article-title":"Total bilirubin in prognosis for mortality in end-stage renal disease patients on peritoneal dialysis therapy","volume":"6","author":"Yang","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.aohep.2023.101177_bib0047","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jhep.2023.06.004","article-title":"Gilbert's syndrome revisited","volume":"79","author":"V\u00edtek","year":"2023","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2023.101177_bib0048","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0021-9150(01)00601-3","article-title":"Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels","volume":"160","author":"V\u00edtek","year":"2002","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.aohep.2023.101177_bib0049","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3390\/antiox10122000","article-title":"Association of serum bilirubin and functional variants of heme oxygenase 1 and bilirubin UDP-glucuronosyl transferase genes in czech adult patients with non-alcoholic fatty liver disease","volume":"10","author":"Petrt\u00fdl","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"10.1016\/j.aohep.2023.101177_bib0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.atherosclerosis.2014.12.042","article-title":"Bilirubin, platelet activation and heart disease: a missing link to cardiovascular protection in Gilbert's syndrome?","volume":"239","author":"Kundur","year":"2015","journal-title":"Atherosclerosis"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268123002806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268123002806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T04:09:40Z","timestamp":1718165380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268123002806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1665268123002806"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2023.101177","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-linear associations of circulating total bilirubin concentration with the risk of nonalcoholic fatty liver disease and all-cause mortality","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2023.101177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101177"}}